MC2 Therapeutics sells rights to psoriasis drug in China
Biotech company MC2 Therapeutics, which markets the psoriasis cream Wynzora in the US and Europe in collaboration with Epi Health and Almirall, respectively, has now also signed an agreement with a Chinese partner that will send millions of Danish kroner to the Danish company.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.